- Home
- PBT vs ARCT Comparison
PBT vs ARCT Comparison
Compare PBT & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBT
- ARCT
- Stock Information
- Founded
- PBT 1980
- ARCT 2013
- Country
- PBT United States
- ARCT United States
- Employees
- PBT N/A
- ARCT N/A
- Industry
- PBT Oil & Gas Production
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- PBT Energy
- ARCT Health Care
- Exchange
- PBT Nasdaq
- ARCT Nasdaq
- Market Cap
- PBT 835.7M
- ARCT 320.8M
- IPO Year
- PBT N/A
- ARCT N/A
- Fundamental
- Price
- PBT $18.49
- ARCT $18.09
- Analyst Decision
- PBT
- ARCT Strong Buy
- Analyst Count
- PBT 0
- ARCT 10
- Target Price
- PBT N/A
- ARCT $50.88
- AVG Volume (30 Days)
- PBT 139.9K
- ARCT 499.7K
- Earning Date
- PBT 01-01-0001
- ARCT 11-06-2025
- Dividend Yield
- PBT 2.93%
- ARCT N/A
- EPS Growth
- PBT N/A
- ARCT N/A
- EPS
- PBT 0.35
- ARCT N/A
- Revenue
- PBT $18,413,820.00
- ARCT $122,122,000.00
- Revenue This Year
- PBT N/A
- ARCT N/A
- Revenue Next Year
- PBT N/A
- ARCT $28.92
- P/E Ratio
- PBT $51.70
- ARCT N/A
- Revenue Growth
- PBT N/A
- ARCT N/A
- 52 Week Low
- PBT $8.01
- ARCT $8.04
- 52 Week High
- PBT $18.80
- ARCT $25.88
- Technical
- Relative Strength Index (RSI)
- PBT 69.58
- ARCT 53.17
- Support Level
- PBT $17.61
- ARCT N/A
- Resistance Level
- PBT $18.80
- ARCT $18.69
- Average True Range (ATR)
- PBT 0.65
- ARCT 1.00
- MACD
- PBT -0.01
- ARCT -0.75
- Stochastic Oscillator
- PBT 87.60
- ARCT 92.77
About PBT Permian Basin Royalty Trust
Permian Basin Royalty Trust is an express trust. The company's underlying properties include Waddell Ranch Properties in which the trust holds mineral interest as well as royalty interests in mature producing oil fields, such as Yates, Wasson, Sand Hills, East Texas, Kelly-Snyder, Panhandle Regular, N. Cowden, Todd, Keystone, Kermit, McElroy, Howard-Glasscock, Seminole and others across Texas. The company earns majority revenue in form of royalties received through its properties.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.